Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-02-22 @ 9:39 AM
Study NCT ID:
NCT04103060
Status:
COMPLETED
Last Update Posted:
2020-11-24
First Post:
2019-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
Sponsor:
Dermavant Sciences GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DMVT-502-2101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None